Internal Medicine, Hematology · Saint Louis, MO
NPI
1215953526
Since 2006
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
4500 Forest Park Ave, Div Im Hematology, 5th Fl
Saint Louis, MO, 63108
Phone (314) 362-7216
Groups this clinician bills Medicare through
Medicare paid, 2024
$362K
42,042 services
Medicare patients, 2024
4,421
Average age 71
Drug cost, 2024
$4.2M
4,562 prescriptions
Company payments, 2025
$22K
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Morey A Blinder was code 85025 (blood count), 17,386 times for 4,292 patients. In total Morey A Blinder billed 42,042 services in 47 codes, and Medicare paid $362K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 85025 Blood Count | Office | 17,386 | 4,292 | $7.60 | $132K |
| 80053 Clinical Chemistry | Office | 12,224 | 3,572 | $10.32 | $126K |
| 83615 Clinical Chemistry | Office | 6,150 | 2,038 | $5.90 | $36K |
| 83735 Clinical Chemistry | Office | 1,504 | 446 | $6.54 | $9,843 |
| 84550 Clinical Chemistry | Office | 1,487 | 462 | $4.42 | $6,578 |
| 84100 Clinical Chemistry | Office | 1,004 | 375 | $4.62 | $4,638 |
| 85045 Blood Count | Office | 663 | 397 | $3.89 | $2,582 |
| 36415 Venipuncture Blood Collection | Office | 279 | 170 | $8.65 | $2,413 |
| 82248 Clinical Chemistry | Office | 279 | 132 | $4.90 | $1,367 |
| 83690 Clinical Chemistry | Office | 179 | 73 | $6.60 | $1,181 |
| 82150 Clinical Chemistry | Office | 171 | 71 | $6.24 | $1,066 |
| 82977 Clinical Chemistry | Office | 157 | 57 | $6.99 | $1,097 |
| 99215 Office E&M - Established | Office | 101 | 56 | $134.36 | $14K |
| 80048 Clinical Chemistry | Office | 93 | 73 | $8.28 | $770 |
| 99214 Office E&M - Established | Office | 60 | 55 | $88.83 | $5,330 |
By year: 2022 $703K for 62,770 services; 2023 $654K for 62,743 services; 2024 $362K for 42,042 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 17,386 | 4,292 | $7.60 | $132K |
| 80053 Clinical Chemistry | 12,224 | 3,572 | $10.32 | $126K |
| 83615 Clinical Chemistry | 6,150 | 2,038 | $5.90 | $36K |
| 83735 Clinical Chemistry | 1,504 | 446 | $6.54 | $9,843 |
| 84550 Clinical Chemistry | 1,487 | 462 | $4.42 | $6,578 |
| 84100 Clinical Chemistry | 1,004 | 375 | $4.62 | $4,638 |
| 85045 Blood Count | 663 | 397 | $3.89 | $2,582 |
| 36415 Venipuncture Blood Collection | 279 | 170 | $8.65 | $2,413 |
| 82248 Clinical Chemistry | 279 | 132 | $4.90 | $1,367 |
| 83690 Clinical Chemistry | 179 | 73 | $6.60 | $1,181 |
Medicare prescription drug claims, 2024
In 2024, the drug Morey A Blinder prescribed most often to Medicare patients was Oxycodone Hcl, with 737 prescriptions and refills. In total Morey A Blinder wrote 4,562 Medicare prescriptions that cost $4.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone Hcl Generic | 737 | 737 | 56 | $7,047 |
| Morphine Sulfate Generic | 491 | 491 | 33 | $14K |
| Methadone Hcl Generic | 400 | 401 | 27 | $4,808 |
| Hydromorphone Hcl Generic | 398 | 398 | 30 | $5,672 |
| Morphine Sulfate Er Morphine Sulfate | 385 | 385 | 28 | $8,222 |
| Eliquis Apixaban | 184 | 212 | 32 | $121K |
| Hydroxyurea Generic | 151 | 268 | 42 | $4,152 |
| Ibuprofen Generic | 134 | 134 | 32 | $678 |
| Xarelto Rivaroxaban | 104 | 162 | 23 | $89K |
| Deferasirox Generic | 102 | 126 | 20 | $43K |
| Gabapentin Generic | 84 | 86 | 16 | $846 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 80 | 80 | 14 | $1,569 |
| Warfarin Sodium Generic | 77 | 143 | 13 | $371 |
| Imbruvica Ibrutinib | 54 | 54 | Under 11 | $835K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 51 | 51 | 11 | $1,160 |
Brand drugs: - claims; generic drugs: 3,395 claims; opioid claims: 2,627.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Morey A Blinder $22K ($22K in general payments such as food, travel and fees) from 11 companies. The largest payer was Genzyme Corporation with $8,924.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 6 | $8,924 |
| Recordati_rare_diseases_inc. | 5 | $7,097 |
| Beckman Coulter, Inc. DHR | 1 | $3,150 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $2,130 |
| Agios Pharmaceuticals, Inc. AGIO | 1 | $141 |
| Pharmacosmos Therapeutics Inc. | 2 | $90 |
| GlaxoSmithKline, LLC. GSK | 4 | $88.65 |
| Novo Nordisk Inc NVO | 3 | $78.52 |
| Sobi, Inc SOBI.ST | 3 | $73.58 |
| PharmaEssentia USA Corporation 6446.TW | 1 | $17.51 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.